Latest News
Feature
Two Senators reach deal on a health law fix
Even if it fails, the deal revives something that has been almost completely missing in Congress for the past 8 years – bipartisan compromise.
Conference Coverage
VIDEO: Mobile stroke units aren’t just expensive toys
Mobile stroke units can deliver stroke diagnosis and treatment, circumventing the transportation time to the emergency department. But are they...
Conference Coverage
MI, stroke risk from HFrEF surpasses HFpEF
DALLAS – Events go up as ejection fraction declines.
Conference Coverage
Keynote 040: Pembrolizumab misses efficacy endpoint in advanced HNSCC
MADRID – Median OS in the ITT population was 8.4 months in the pembrolizumab arm, vs. 7.1 months in the standard-of-care arm.
Feature
Cascade of costs could push new gene therapy above $1 million per patient
Although Kymriah’s price tag has “shattered oncology drug-pricing norms,” Dr. Saltz said “the sticker price is just the starting point.”
From the Journals
High EZH2 expression a marker for death risk in RCC
Tumor levels of the oncogenic protein were predictive of death even among patients considered at low or intermediate risk by a standard prognostic...
From the Journals
Biomarker predicts CYP17A1-inhibitor response in prostate cancer
Median PFS increased along with the number of variant HSD3B1(1245C) alleles, in an observational study of men with castration-resistant prostate...
News from the FDA/CDC
Reconstruction becoming more common after mastectomy
Nonsimultaneous procedure has gained popularity and moved out of the hospital.
Conference Coverage
PFS better with first-line pazopanib vs. sorafenib in mRCC
MADRID – The drug sequence matters when it comes to the treatment of advanced or metastatic renal cell carcinoma (mRCC) investigators have found....
Conference Coverage
ExteNET: Benefit of extended neratinib in HER2+ breast cancer sustained
MADRID – The 5-year iDFS rate was 90.2% for patients assigned to neratinib, compared with 87.7% for those assigned to placebo.
Video
MACRA Monday: Advance care plan
Avoid a 4% penalty under MIPS by reporting that you discussed advance care planning with one patient.